pfizer - Search News

News

Pfizer Raises Profit Outlook

Reuters on MSN · 3h

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday. CEO Albert Bourla also said the company has been in active discussions with members of the U.

The Wall Street Journal on MSN · 3h

Pfizer Raises Profit Outlook as Uncertainty Lingers Over Tariffs, Drug Prices

Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.

MarketWatch · 3h

Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance

Pfizer Inc. (NYSE: PFE) reported financial results for the second quarter of 2025 and reaffirmed its 2025 Revenue guidance while raising guidance (1) for Adjusted (2) diluted EPS. EXECUTIVE COMMENTARY Dr.

ap, Q2 and Pfizer

Pfizer beats in Q2 earnings, reaffirms 2025 outlook

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 billion in revenues. The company reported revenues of $14.7 billion, compared to Wall Street expectations of $13.5 billion, and earnings per share of $0.78, versus estimates of $0.58 per share.

Houston Chronicle · 9h

Pfizer: Q2 Earnings Snapshot

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share. The drugmaker posted revenue of $14.65 billion in the period, also topping Street forecasts.

NNN REIT: Q2 Earnings Snapshot

NNN REIT, Inc (NNN) on Tuesday reported a key measure of profitability in its second quarter. The results topped Wall Street expectations.

27m

Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

6m

Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing

Pfizer CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the COVID-19 ...

6h

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

2h

Pharma prepared to work with Trump on DTC drug sales: Pfizer CEO

Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...

6h

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

Schaeffer's Investment Research4h

Pfizer Stock Pops on Q2 Beat-and-Raise

Pfizer (PFE) stock is rising after the company reported strong second-quarter earnings and lifted its full-year forecast ...

2h

Palantir still surging, Pfizer pops, Fox's new streaming platform

Yahoo Finance's John Hyland tracks Tuesday's top moving stocks and biggest market stories in this Market Minute. Palantir ...

2hon MSN

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain.

Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results